DENTSPLY SIRONA Inc.: amends credit and note purchase agreements

What happened

• The filing says DENTSPLY SIRONA Inc. obtained lender consent under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to enter into a Third Amendment to Credit Agreement dated as of Sep 30, 2026.
• The filing says that on Oct 8, 2026 the company entered into three Note Purchase Agreement Amendments (each dated as of Sep 30, 2026) with the applicable noteholders, including an amendment involving DENTSPLY DENTAL B.V. (as successor by merger to Sirona Dental Services GmbH).

Key details

• The Third Amendment and the Note Purchase Agreement Amendments (dated Sep 30, 2026) (a) increase the maximum permitted Total Leverage Ratio and the maximum permitted Senior Leverage Ratio for the fiscal quarters ending Sep 30, 2026 and Dec 31, 2026; and (b) permit an additional addback to EBITDA for certain cash charges or expenses incurred during those fiscal quarters.
• Until delivery of a compliance certificate for the fiscal year ending Dec 31, 2026, the amendments (A) generally prohibit new liens and new subsidiary debt other than those existing before Sep 30, 2026 and (B) limit restricted payments with certain carveouts.
• The Third Amendment adds a new pricing level for the applicable margin and facility fee; the Note Purchase Agreement Amendments increase incremental interest on the notes if the company’s total leverage ratio equals or exceeds specified thresholds.
• The amendments add certain quarterly reporting requirements on initiatives and related costs and savings during a specified period. The filing says the revised terms are intended to allow the company to maintain compliance with its debt covenants in all material respects.

Why it may matter

• This is Item 1.01: entry into a material definitive agreement, which covers amendments to the company’s credit facility and its note purchase agreements.
• This filing does not show why the company acted.